Regeneron: Is Eylea At Risk? By: Stocks to Watch June 21, 2017 at 11:59 AM EDT An experimental eye drug from Novartis could rival Regeneron's blockbuster drug Eylea. What does that mean for Regeneron's stock price? Read More >>